Related Experiment Videos
On the clinical meaningfulness of a treatment's effect on a time-to-event variable
1Amgen Inc., One Amgen Center Drive, 24-2-C, Thousand Oaks, CA 91320, USA. ssnapinn@amgen.com
Abstract:
The standard analysis of a time-to-event variable often involves the calculation of a hazard ratio based on a survival model such as Cox regression; however, many people consider such relative measures of effect to be poor expressions of clinical meaningfulness. Two absolute measures of effect are often used to assess clinical meaningfulness: (1) many disease areas frequently use the absolute difference in event rates (or its inverse, the number-needed-to-treat) and (2) oncology frequently uses the difference between the median survival times in the two groups. While both of these measures appear reasonable, they directly contradict each other. This paper describes the basic mathematics leading to the two measures and shows examples. The contradiction described here raises questions about the concept of clinical meaningfulness.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Kaplan-Meier Approach
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Clinical Trials
There are four phases in a clinical trial. A phase one...
The Mantel-Cox Log-Rank Test